LC
CLB icon

Landaas & Company’s Core Laboratories CLB Stock Holding History

Landaas & Company’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-114
Closed -$14K – 108
2018
Q2 		$14K Buy
+114
New +$13.9K 0.01% 242
2018
Q1 		– Sell
-114
Closed -$12K – 101
2017
Q4 		$12K Hold
114
– – 0.01% 238
2017
Q3 		$11K Buy
+114
New +$11.1K 0.01% 243

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Landaas & Company's CLB Position: Q3 2018 in Review

Landaas & Company sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 114 shares — an estimated $14K sold.

Landaas & Company first reported a position in CLB in Q3 2017 and held it in 3 quarters. The position peaked at $14K in Q2 2018. 360 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Landaas & Company reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 114 Core Laboratories shares in Q3 2018, an estimated $14K.
  • Landaas & Company first reported a position in Core Laboratories in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Core Laboratories position peaked at $14K in Q2 2018.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.